U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > Epilepsy, familial temporal lobe, 1

Summary

Excerpted from the GeneReview: Autosomal Dominant Epilepsy with Auditory Features
Autosomal dominant epilepsy with auditory features (ADEAF) is a focal epilepsy syndrome with auditory symptoms and/or receptive aphasia as prominent ictal manifestations. The most common auditory symptoms are simple unformed sounds including humming, buzzing, or ringing; less common forms are distortions (e.g., volume changes) or complex sounds (e.g., specific songs or voices). Ictal receptive aphasia consists of a sudden onset of inability to understand language in the absence of general confusion. Less commonly, other ictal symptoms may occur, including sensory symptoms (visual, olfactory, vertiginous, or cephalic) or motor, psychic, and autonomic symptoms. Most affected individuals have focal to bilateral tonic-clonic seizures, usually accompanied by "focal aware" and "focal impaired-awareness" seizures, with auditory symptoms as a major focal aware seizure manifestation. Some persons have seizures precipitated by sounds such as a ringing telephone. Age at onset is usually in adolescence or early adulthood (range: age 4-50 years). The clinical course of ADEAF is benign. Seizures are usually well controlled after initiation of medical therapy.

Available tests

39 tests are in the database for this condition.

Check Related conditions for additional relevant tests.

Genes See tests for all associated and related genes

  • Also known as: ADLTE, ADPAEF, ADPEAF, EPITEMPIN, EPT, ETL1, IB1099, LGI1
    Summary: leucine rich glioma inactivated 1

  • Also known as: MICAL, MICAL-1, NICAL, MICAL1
    Summary: microtubule associated monooxygenase, calponin and LIM domain containing 1

  • Also known as: ETL7, LIS2, PRO1598, RL, RELN
    Summary: reelin

Clinical features

Help

Show allHide all

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.